about
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targetsTransforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma.microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.Novel lysophosphoplipid receptors: their structure and function.microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survivalSwitching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer CellsShaping the landscape: metabolic regulation of S1P gradients.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.Plasma sphingolipids and lung cancer: a population-based, nested case-control study.Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.Dynamic Cross Talk between S1P and CXCL12 Regulates Hematopoietic Stem Cells Migration, Development and Bone RemodelingSphingosine 1-Phosphate Receptor Modulators and Drug Discovery.Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo.Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway.Targeting sphingosine-1-phosphate signaling for cancer therapy.Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations.Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies.Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer."Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.New insights on the Intrinsic, Pro-Apoptotic Effect of IGFB3 in Breast Cancer.Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast.Classification of sphingosine kinase inhibitors using counter propagation artificial neural networks: A systematic route for designing selective SphK inhibitors.TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling.Sphingosine-1-phosphate receptors and innate immunity.
P2860
Q27000801-5B9BC3FA-6D6C-430E-BC29-0190A68148ACQ27853204-795F59A3-5F72-4700-9A88-7A03D10EB416Q28541360-5CA3016D-FFDF-470D-8B17-6EB660B44630Q30252641-C4BB2FF0-4D32-48B4-B40D-7DBED8AEB010Q30360636-FED297C3-6921-41F7-BDFB-4AD021D38A6AQ33598751-9E8D16EA-E5B8-4E44-A553-8E3163D8408EQ33757112-503B568D-8CFF-4848-991C-C40F67733101Q34238610-CF2C0B2C-0A46-4AB1-9AE7-4F2075ACA67FQ34795479-FB9234CA-DDAB-4173-B1D3-D55E7C9A1ED0Q34797919-2BA92548-33A2-41FC-B9C8-D3B4C6092995Q35249824-7A74006E-C74A-4BC4-A86C-03E9014ED279Q35845319-2E09FF81-90F0-4DC7-97F8-CB8F574745F3Q36356934-7019544D-DB47-4E92-8505-EBC9D6D50C14Q36656870-8C70633C-F8D6-470B-8F88-F7CB85D84316Q36886386-273E9F46-E389-41D6-9812-EE69367A6BB2Q37005458-76528285-4B60-4876-85EF-FB77E9CB7AD8Q37069137-6BEC1CB4-2011-4A02-9066-3294D999920AQ37190258-97880B1E-62D2-4D85-9E9E-A94922888CADQ37283464-F2973858-6BAA-4B88-AD48-2A8AFA996920Q37551932-07F69188-69CE-42FF-B541-7912AFC8D3BEQ37697046-49C9F40B-129A-4557-9424-5704788C14C2Q37726630-F06A0EFD-D94E-411F-8067-7B7E98769C57Q38166800-2445E7DC-A170-4386-8E76-A4CD95264CFCQ38682530-AC9E528A-48F1-4D18-9397-4F95CC873EF8Q38795539-927179DE-DE57-4715-8D3D-C010CA595A74Q39379449-E1ABDE0D-D8A1-4C0E-BE71-56F3BB982885Q39959298-78920079-9575-46D0-AD0B-E40183DA5B07Q40113378-1798BB75-3CB1-4C1F-B9E4-173B893E20CBQ41098262-05E2FAC5-4F10-4FA0-A799-F298A2B62AE7Q41622885-C1237E72-4593-4C46-A30C-4B834654A636Q41661043-E1ED4838-55BB-407A-A4FE-BA4993BF3A2FQ42953617-26A02A24-E728-493C-BD6C-A279A6E22955Q47094102-9D69F1A8-D6B2-4CE5-BC79-1BC27370976FQ47193833-919D1BFD-247F-4602-A885-D911231F8AEBQ47996348-4A9E86AC-A214-456E-887F-72C186AD64B6Q48219620-7345D2EC-36E9-4274-957B-D693DAC4E438Q50098292-7C9E0F24-67EB-4B3F-8FBA-CE8D09B81FD1Q50462945-C6D8A268-E7AE-4B10-81C5-B733147A9E82Q51034812-1AE1BC6E-9AE5-4D0E-907F-12695EC3A03CQ52677659-4E4C90B4-1A8E-4BC4-BDAA-2C48F05B4CC3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sphingosine 1-phosphate signalling in cancer.
@en
Sphingosine 1-phosphate signalling in cancer.
@nl
type
label
Sphingosine 1-phosphate signalling in cancer.
@en
Sphingosine 1-phosphate signalling in cancer.
@nl
prefLabel
Sphingosine 1-phosphate signalling in cancer.
@en
Sphingosine 1-phosphate signalling in cancer.
@nl
P2093
P2860
P356
P1476
Sphingosine 1-phosphate signalling in cancer.
@en
P2093
Francesca Tonelli
Jaclyn S Long
Joanne Edwards
Keng Gat Lim
Nigel J Pyne
Susan Pyne
P2860
P304
P356
10.1042/BST20110602
P577
2012-02-01T00:00:00Z